Clinical Trials Logo

Filter by:
NCT ID: NCT04138927 Enrolling by invitation - Clinical trials for Warm Antibody Autoimmune Hemolytic Anemia

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Start date: October 30, 2019
Phase: Phase 3
Study type: Interventional

The primary objective of this study is: • To evaluate the long-term safety of fostamatinib in subjects with warm antibody autoimmune hemolytic anemia (wAIHA).

NCT ID: NCT04135313 Enrolling by invitation - Rectal Cancer Clinical Trials

Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer

RuCorT-03
Start date: October 20, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether the addition of 2 cycles of induction CapOx chemotherapy and 2 cycles of consolidation CapOx chemotherapy to standard chemoradiation improves 3-year disease-free survival in patients with locally advanced CRM"+" mid and low rectal cancer.

NCT ID: NCT04134897 Enrolling by invitation - Rectal Cancer Clinical Trials

Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer

RuCorT-02
Start date: October 14, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether 3 months of neoadjuvant CapOx is non-inferior to neoadjuvant radiotherapy in patients with moderate risk CRM"-" mid rectal cancer.

NCT ID: NCT04103697 Enrolling by invitation - Rectal Cancer Clinical Trials

Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer

RuCorT-01
Start date: August 1, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether 4 cycles of neoadjuvant CapOx chemotherapy is more effective than the upfront surgery in patients with intermediate risk CRM"-" mid and upper rectal cancer.

NCT ID: NCT04011943 Enrolling by invitation - Ulcerative Colitis Clinical Trials

Fecal Microbiota Transplantation for Health Improvement (TFM3)

TFM3
Start date: May 21, 2018
Phase: N/A
Study type: Interventional

Search for mechanisms of the effect of fecal transplantation on a healthy organism and various nosological forms.

NCT ID: NCT03891446 Enrolling by invitation - Ocular Hypertension Clinical Trials

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

Maia
Start date: March 27, 2019
Phase: Phase 3
Study type: Interventional

This study will evaluate the long-term safety and efficacy of Bimatoprost Sustained Release (SR) in patients with open-angle glaucoma or ocular hypertension who completed 1 of the 4 Phase 3 Bimatoprost SR studies (192024-091, -092, -093, or -095) and received Bimatoprost SR or who received commercial DURYSTA (Bimatoprost SR) in the open-label Phase 4 ARGOS study (MED-MA-EYE-0648) and completed (or exited early from) the study.

NCT ID: NCT03827616 Enrolling by invitation - Prostatic Neoplasms Clinical Trials

Moderately Hypofractionated Radiotherapy for Prostate Cancer.

Start date: January 25, 2019
Phase: Phase 2
Study type: Interventional

Radiation therapy is one of the standard treatments for men with prostate cancer. Moderately hypofractionated radiotherapy has been established to be equivalent to standard fractionated radiotherapy in several large randomized clinical trials, however different hypofractionated regimens have been used in these studies. The two most common hypofractionated regimens are 70 Gy in 28 fractions and 60 Gy in 20 fractions, both are considered standard of care, however it is not unknown which regimen is better in terms of effectiveness and toxicity. The aim of this randomized controlled clinical trial is to compare the two hypofractionated radiotherapy regimens using Helical Tomotherapy.

NCT ID: NCT03762967 Enrolling by invitation - Azoospermia Clinical Trials

Autologous Adipose-Derived Adult Stromal Vascular Cell Administration for Male Patients With Infertility

Start date: March 12, 2018
Phase: Phase 2
Study type: Interventional

Severe Oligospermia (oligozoospermia) refer to semen with a low concentration of sperm and is a common finding in male infertility. Often semen with a decreased sperm concentration may also show significant abnormalities in sperm morphology and motility that affect Male fertility. The purpose of this study is to assess the ability of Autologous Adipose-Derived Adult Stromal Vascular Fraction (SVF) cells to stimulate Sertoli and spermatogonia cells and affect male fertility.

NCT ID: NCT03229200 Enrolling by invitation - Solid Tumor Clinical Trials

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

Start date: May 22, 2017
Phase: Phase 4
Study type: Interventional

Multicenter, open-label, prospective treatment protocol that provides continued access to ibrutinib to subjects who have completed parent ibrutinib studies, are still benefitting from treatment with ibrutinib, and have no access to commercial ibrutinib for their underlying disease within their region.

NCT ID: NCT03205670 Enrolling by invitation - Urethral Stricture Clinical Trials

Tissue-engineered Construct Based on Buccal Mucosa Cells and Matrix From Collagen and Polylactoglycolide Fibers

Start date: June 1, 2017
Phase: Early Phase 1
Study type: Interventional

This study investigates safety and efficacy of surgical treatment of patients with anterior urethral stricture using a tissue-engineered construct based on autologous buccal mucosa cells and matrix from reconstituted collagen and reinforcing polylactoglycolide fibers. This is a single arm study with no control. Success will be assessed via objective and subjective methods; complications will be tallied in a standardized fashion. Outcomes will be measured at five years.